Niinuma S, Kawajiri K, Toida I
Japan BCG Labortory, Tokyo, Japan.
Kekkaku. 1995 Dec;70(12):685-90.
The potency of PPD is very stable when kept as a lyophilized preparation or as a solution of high concentrations, but, as is well known, when diluted to the practical concentrations such as used in skin-testing for human, its potency diminishes rather rapidly. It has been considered that such decrease in potency is not due to denaturation of PPD, but due to its adsorption onto the surface of glass- or plastic-container. The adsorption of PPD had been studied by several authors with radiolabeled PPD or by the potency test in experimental animals or human. However, either method is not satisfactory because they are not quantitative and reproducible. Consequently, we developed a new method basing on ELISA to measure such low concentrations of PPD as used in skin-testing in human. Using this new method, we analyzed the adsorption of PPD onto glass-surface. The major characteristics of the PPD adsorption revealed by the present studies are as follows; (1) The adsorption of PPD takes place very rapidly immediately after the distribution of PPD solution to a new container and then proceeds in slower rates. (2). The rate of adsorption is influenced by both temperature and concentration of PPD solution. The rates of adsorption are almost the same at -80 degrees C and at 6 degrees C, much higher at 22 degrees C and further higher at 37 degrees C at any concentration tested. At -80 degrees C and 6 degrees C, there is no difference among the adsorption rates at three different concentrations, but at 22 degrees C and 37 degrees C, the rate of adsorption at the lowest concentration (0.25 microgram/ml) is much higher than those at higher concentrations. (3) The amounts of PPD adsorbed are determined by the surface area of glass in contact with PPD solution. (4) The larger the volume of PPD solution distributed, the bigger the absolute amount of PPD adsorbed, but the smaller the rate of adsorption. (5) So-called "volume effects" are evidenced. Commercially available Japanese PPD preparations have been produced and adjusted their potency taking such adsorption phenomena into consideration. But, if undue adsorption is induced by unappropriate handling and/or usage, the potency might be diminished. Especially, the single-dose preparation may be affected most strongly by so-called "volume-effects". Standard handling and usage recommended by the manufacturer are strictly required.
结核菌素纯蛋白衍生物(PPD)制成冻干制剂或高浓度溶液时,其效价非常稳定。但众所周知,稀释至人体皮肤试验所用的实际浓度时,其效价会迅速降低。人们认为这种效价降低并非由于PPD变性,而是由于其吸附在玻璃或塑料容器表面。几位作者曾用放射性标记的PPD或通过在实验动物或人体上进行效价试验来研究PPD的吸附情况。然而,这两种方法都不尽人意,因为它们不具有定量性和可重复性。因此,我们开发了一种基于酶联免疫吸附测定(ELISA)的新方法,用于测量人体皮肤试验中使用的低浓度PPD。使用这种新方法,我们分析了PPD在玻璃表面的吸附情况。本研究揭示的PPD吸附的主要特征如下:(1)PPD溶液分配到新容器后,吸附立即迅速发生,然后以较慢的速率进行。(2)吸附速率受温度和PPD溶液浓度的影响。在测试的任何浓度下,-80℃和6℃时的吸附速率几乎相同,22℃时高得多,37℃时更高。在-80℃和6℃时,三种不同浓度下的吸附速率没有差异,但在22℃和37℃时,最低浓度(0.25微克/毫升)的吸附速率远高于较高浓度时的吸附速率。(3)吸附的PPD量由与PPD溶液接触的玻璃表面积决定。(4)分配的PPD溶液体积越大,吸附的PPD绝对量越大,但吸附速率越小。(5)存在所谓的“体积效应”。日本市售的PPD制剂在生产时已考虑到这种吸附现象并调整了效价。但是,如果因不当处理和/或使用导致过度吸附,效价可能会降低。特别是,单剂量制剂可能受所谓“体积效应”的影响最大。严格要求遵循制造商推荐的标准处理和使用方法。